
Cancer Drug Prices in India Rise Up to 700% Despite NPPA Caps: Why Patients Still Face High Costs
India’s cancer-drug pricing debate has intensified after an analysis found trade mark-ups of up to 700% on some anti-cancer medicines, despite the National Pharmaceutical Pricing Authority’s…





















